Diagnosing prostate cancer at a curable stage means providing PSA tests to asymptomatic patients
BMJ
.
2022 Jul 12:378:o1714.
doi: 10.1136/bmj.o1714.
Authors
Christopher M Booth
1
,
Frank Chinegwundoh
2
,
Stephen Allen
3
,
Hendrik Van Poppel
4
Affiliations
1
CHAPS, Colchester, UK.
2
London, UK.
3
Tackle Prostate Cancer, Reading, UK.
4
EAU Policy Office, Leuven, Belgium.
PMID:
35820680
DOI:
10.1136/bmj.o1714
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Immunologic Tests
Male
Prostate-Specific Antigen*
Prostatic Neoplasms* / diagnosis
Substances
Prostate-Specific Antigen